The IPOX® Week, April 10, 2017

  • IPOX U.S. Indexes lag foreign counterparts as international IPO activity outpaces the U.S.
  • IPOX-linked ETF performance update, AUM rise.
  • Q2 sees surge in global deals, upcoming IPOs.

IPOX U.S. Indexes lag foreign counterparts as international IPO activity outpaces the U.S. The performance of the IPOX Indexes mirrored the pattern in global IPO activity last week as deal volume abroad surpassed deal flow in the United States. In the IPOX Indexes Universe, while renewed weakness in U.S. small-caps pressured the IPOX 100 U.S. Index (IPXC, IPXO, IPXT), big momentum in specialty deals drove the IPOX Europe Indexes (IXTE, IPND) and IPOX International (IPXI) to multi-year highs. Individual names driving relative and absolute gains in the IPOX Europe (IXTE), e.g., continued to include French engineering services provider SPIE (SPIE FP: +6.04%), 15’ Bayer Spin-off specialty chemicals maker Covestro (1COV GY: +5.63%) or Italian high-end luxury apparels maker Moncler (MONC IM: +4.14%). In the IPOX International (IPXI) – benchmark for the performance of the largest and best performing IPOs and Spin-offs with a domicile outside the U.S. – other big movers included recent Spin-off Chinese restaurant operator Yum China (YUMC US: +14.52%), Chinese social networker ever-volatile Meitu (1357 HK: +8.28%) or Japan transit provider 10/16 IPO Kyushi Railway Group (9142 JP: +3.94%). We also note a fresh all-time high in IPOX Asia-Pacific (IPTA)-tracked “British International School” operator Nord Anglian Education (NORD US: +10.10%). Firms recording downside were mostly U.S. domiciled and linked to Monday’s release of U.S. car sales, such as Camping World (CWH US: -11.20%), auto parts maker Adient (ADNT US: -8.01%) and car producer Fiat Chrysler (FCAU US: -7.41%).

IPOX Price Returns (%) Last Week Q1 2017 2017 YTD
Exposure: Global/International (xUS) (USD)
IPOX Global (IPGL50) -0.13 8.33 8.19
IPOX International (IPXI)* 0.39 11.49 11.93
Exposure: United States
IPOX Composite U.S. (IPXC)* -0.46 9.26 8.76
IPOX 100 U.S. (IPXO)* -0.81 6.12 5.26
IPOX 30 U.S. (IPXT) -0.83 5.90 5.02
Exposure: Europe/Nordic Region
IPOX Europe (IXTE) 0.80 9.03 9.90
IPOX Nordic (IPND) 1.07 3.84 4.95
Exposure: Asia-Pacific/China Region
IPOX Asia-Pacific (IPTA) -0.02 8.32 8.29
IPOX China C. (IPXUCHCHP)* 0.98 11.44 12.53
IPOX China (CNI) 0.80 11.52 12.41

* Basis for ETPs: FPX US, FPX LN, FPXU FP, FPXI US, TCIP110 IT) and CME Futures (e-mini IPOX 100 U.S. Index Futures [commodity trading symbol: IPOM7]).

IPOX-linked ETF performance update, AUM rise. Amid continued brisk activity in the global New Listings Market, select IPOX-linked investment products traded mixed last week, but saw a net increase in AUM. The IPOX-linked, 5-star, 10-year old 700.15 million First Trust U.S. Equity Opportunity ETF (FPX) fell to +5.48% YTD, e.g., while the First Trust International IPO ETF (FPXI) rose for yet another week, extending its YTD gain by +0.52% to +13.09% YTD.

Q2 sees surge in global deals, upcoming IPOs. A massive 15 notable global IPOs (non China-A shares) commenced trading last week with the average (median) equally-weighted IPO gaining +5.23% (+0.99%) based on the difference between the final offering price and the week’s close. In the cross-section, while U.S. IPOs continued to be significantly underpriced (average initial return: +16.55%, median: +13.96%), firms abroad left virtually no money on the table (average initial return +1.11%, median: +0.00%). While the valuation consumer lender Elevate Credit (ELVT US: +15.31%) was almost cut in half (!!!) into the IPO, negative sentiment around incumbent ’10 IPO Swift (SWFT US: -2.53%) pressured the IPO of Schneider National (SNDR US: +0.00%). The strong debut in applications software maker Okta (OKUS: +38.29%) underlined indiscriminate demand for specialty deals in the U.S. Ahead of the shortened trading week, 9 sizeable firms debuted in Europe. Focus during the upcoming week shifts back to the U.S., with at least 6 companies from various industries lined up to go public on the NYSE or NASDAQ.

Traded IPOs (week of 04/03/2017) Country
Actic Group AB Sweden
Banca Farmafactoring SpA Italy
Bergenbio ASA Norway
Elevate Credit Inc. United States
Galenica Sante Ltd Switzerland
Gestamp Automocion SA Spain
Hess Midstream Partners LP United States
Isofol Medical AB Sweden
Kunming Dianchi Water Treatment Co Ltd China
Okta Inc. United States
Schneider National Inc United States
SSM Holding AB Sweden
Unieuro SpA Italy
X-Fab Silicon Foundries SE Belgium
Upcoming IPOs (week of 04/10/2017) Country
Azul SA Brazil
Cadence BanCorp United States
FM Mattsson Mora Sweden
Nanobiotix France
Netmarble Games Corp South Korea
Netshoes Cayman Ltd Brazil
Oceania Healthcare Ltd New Zealand
Tocagen Inc United States
Yext Inc. United States
Warrior Met Coal LLC United States

Josef Schuster is the founder of IPOX Schuster LLC (, a Chicago-based Financial Services company specialized in Financial Products Design related to Initial Public Offerings and corporate Spin-offs. He is the chief architect of the IPOX Indexes, a global index group initiated in 2004 that encompasses an index technology allowing for asset-allocation focused exposure to the “going public” effect associated with global IPOs and Spin-offs. Mr. Schuster earned his Bachelor of Arts degree in Business Administration in 1994 from the European Business School, London. Mr. Schuster was also awarded a MSc in Accounting and Finance in August 1996 and a MPhil / PhD in Accounting and Finance in June 2003 from the London School of Economics.

ABOUT THE IPOX INDEXES: Through the range of the IPOX Indexes, market participants have an innovative opportunity to navigate the global IPO and Spin-off market and to track the performance of this economically significant sector more accurately and comprehensively than with any other index group. The IPOX Indexes accomplish the systematic indexation of the aftermarket performance of the IPO and Spin-off sector, while – at the same time – preserving the benefits of diversification. Linked to the IPOX 100 U.S. Index, for example, IPOX-linked investment products available to investors include the pioneering USD million 600, 5-star First Trust U.S. IPO ETF (ticker: FPX). On February 18, 2016, CME Group, the world’s largest exchange operator, launched e-mini IPOX 100 U.S. Index Futures, offering market participants for the first time a tool to manage the aggregate risk associated with U.S. IPOs and Spin-offs.

Disclosure: the author has no position in the stocks mentioned.

Lightspeed Financial Services Group LLC is not affiliated with these third-party market commentators/educators or service providers. Data, information, and material (“content”) are provided for informational and educational purposes only. This content neither is, nor should be construed as an offer, solicitation, or recommendation to buy or sell any securities or contracts. Any investment decisions made by the user through the use of such content is solely based on the users independent analysis taking into consideration your financial circumstances, investment objectives, and risk tolerance. Lightspeed Financial Services Group LLC does not endorse, offer nor recommend any of the services or commentary provided by any of the market commentators/educators or service providers and any information used to execute any trading strategies are solely based on the independent analysis of the user.

You may also be interested in...

The IPOX® Week, October 25th, 2021
Read More
Bank Stocks Kick Of Q3 Earnings Season With A Bang
Read More
The IPOX® Week, October 18th, 2021
Read More
4 Bad Habits That Stock Traders Should Break
Read More

Try the demo

Compare Platforms
Check the background of this firm on FINRA's BrokerCheck

Our website uses cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site in our Privacy Policy. By clicking OK, you agree to allow us to collect information through cookies.